SharonAI Holdings Inc SHAZ Q1 2026 Earnings Severe EPS Miss Yet Stock Surges 18 as Market Looks Past Losses Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 RELX Q2 2025 Earnings EPS Edges Past Estimates Amid Steady Performance BSVN Q1 2026 Earnings EPS Surges Past Estimates by 21 Vaxcyte Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Investment Phase CDP Q1 2026 Earnings EPS Beats Estimates by 2 Stock Slips Modestly